For Immediate Release
Contact: Rob Grant, Communications Director
202.966.7300, Ext. 119
rgrant@aacap.org
Amanda Greenberg, Communications Coordinator
202.966.7300, Ext. 154
agreenberg@aacap.com
Washington, D.C., September 16, 2009 – The American Academy of Child and Adolescent Psychiatry (AACAP) is proud to announce its new practice parameter on the use of psychotropic medications in children and adolescents.
“The reason for the parameter was to ground prescribers of psychotropic medication in the best practice principles,” states principle author John Walkup, M.D. “This is not a standard of care document and is not meant to reduce prescribing. Rather, it is a call for action to create a systematic and comprehensive approach to using medications in children safely and effectively.”
The parameter specifically outlines best practices for: psychiatric and medical assessment, development of the treatment and monitoring plan, educating both the patient and family about the disorder and treatment, implementation of the treatment plan and management of medication modification plans.
The full practice parameter is featured in the Journal of the American Academy of Child & Adolescent Psychiatry, September 2009 – Volume 48 – Issue 9, pages 961 – 973.
To schedule an interview with a child and adolescent psychiatrist or to discuss this practice parameter, please contact Amanda Greenberg, Communications Coordinator, at 202.966.7300, ext. 154 or agreenberg@aacap.org
###
Representing over 7,500 child and adolescent psychiatrists nationwide, the American Academy of Child and Adolescent Psychiatry (AACAP) is the leading authority on children’s mental health.
AACAP Members actively research, diagnose and treat psychiatric disorders affecting children, adolescents and their families. For more information please visit www.aacap.org.
Contact: Rob Grant, Communications Director
202.966.7300, Ext. 119
rgrant@aacap.org
Amanda Greenberg, Communications Coordinator
202.966.7300, Ext. 154
agreenberg@aacap.com
Washington, D.C., September 16, 2009 – The American Academy of Child and Adolescent Psychiatry (AACAP) is proud to announce its new practice parameter on the use of psychotropic medications in children and adolescents.
“The reason for the parameter was to ground prescribers of psychotropic medication in the best practice principles,” states principle author John Walkup, M.D. “This is not a standard of care document and is not meant to reduce prescribing. Rather, it is a call for action to create a systematic and comprehensive approach to using medications in children safely and effectively.”
The parameter specifically outlines best practices for: psychiatric and medical assessment, development of the treatment and monitoring plan, educating both the patient and family about the disorder and treatment, implementation of the treatment plan and management of medication modification plans.
The full practice parameter is featured in the Journal of the American Academy of Child & Adolescent Psychiatry, September 2009 – Volume 48 – Issue 9, pages 961 – 973.
To schedule an interview with a child and adolescent psychiatrist or to discuss this practice parameter, please contact Amanda Greenberg, Communications Coordinator, at 202.966.7300, ext. 154 or agreenberg@aacap.org
###
Representing over 7,500 child and adolescent psychiatrists nationwide, the American Academy of Child and Adolescent Psychiatry (AACAP) is the leading authority on children’s mental health.
AACAP Members actively research, diagnose and treat psychiatric disorders affecting children, adolescents and their families. For more information please visit www.aacap.org.
